Michael Pearson, outgoing CEO of Valeant, will cooperate with a Senate panel investigating increases in the prices of certain prescription drugs by agreeing to appear at a deposition next week.
from WSJ.com: US Business http://ift.tt/1SMGsYa
via IFTTT
No comments:
Post a Comment